Le Lézard
Classified in: Health, Science and technology
Subject: PER

KEPRO Appoints John Malanowski as Chief People Officer


NASHVILLE, Tenn., July 23, 2019 /PRNewswire/ -- KEPRO announced on Tuesday the addition of John Malanowski to the company's executive leadership team as chief people officer, effective July 22, 2019.

Malanowski joins KEPRO with over three decades of global human resource executive experience in leading private and public health care and technology companies. Most recently, he served as interim chief human resource officer for Virence Health Technologies and University of Texas, Southwestern Medical Center.

"In order to continue growing a culture that attracts, retains and develops a high-performing team, we knew we needed an experienced human resources leader to drive workforce initiatives across the enterprise," said KEPRO CEO Joel Portice. "Malanowski's experience in developing and leading a motivated organization will greatly benefit KEPRO, including our employees, customers and their beneficiaries."

Bringing deep expertise in human resource leadership, with a focus on performance driven results, Malanowski will lead all human resource activities in support of the overall business plan and strategic direction across the 1,400-employee enterprise.

"I'm excited to join a strong and innovation-driven executive team," said Malanowski. "People are critical to KEPRO's success and I'm looking forward to teaming with the organization's talented workforce to execute on key human resource strategies."

In this role, Malanowski will be focusing on all aspects of the human resource strategy for corporate colleagues, as well as developing strategies for those that work in state, federal and commercial programs. This includes talent management, leadership development, compensation and benefits.

Malanowski holds a bachelor's degree in science from State University of New York College at Buffalo and a master's degree in labor and industrial relations from Michigan State University.

ABOUT KEPRO

KEPRO is a leading provider of technology-enabled services that offers innovative and outcomes-focused solutions to reduce the utilization of healthcare resources and optimize the quality of care for public and commercial clients. With 15 local offices and 1,400 employees across the United States, KEPRO delivers intelligent value through improved health outcomes and reduced costs, serving more than 55 million beneficiaries. For more information, visit www.kepro.com.

Media Contact: Lauren Portice, Marketing and Communications Manager, [email protected], 717.564.8288 x0233

SOURCE KEPRO


These press releases may also interest you

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...



News published on and distributed by: